0001104659-24-027581.txt : 20240226
0001104659-24-027581.hdr.sgml : 20240226
20240226170236
ACCESSION NUMBER: 0001104659-24-027581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubin Jonathan
CENTRAL INDEX KEY: 0001836067
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 24679991
BUSINESS ADDRESS:
BUSINESS PHONE: 3018382500
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm247055-12_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-22
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001836067
Rubin Jonathan
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
0
1
0
0
SVP, Chief Medical Officer
0
Common Stock
2024-02-22
4
A
0
750
0
A
4261
D
Common Stock
2024-02-22
4
F
0
303
27.94
D
3958
D
Restricted Stock Unit
2024-02-22
4
D
0
750
0
D
Common Stock
750
1500
D
Restricted Stock Unit
2024-02-22
4
A
0
5000
0
A
Common Stock
5000
5000
D
Employee Stock Option (Right to Buy)
27.94
2024-02-22
4
A
0
25000
0
A
2034-02-22
Common Stock
25000
25000
D
Includes an aggregate of 268 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025.
The option vests in four equal annual installments beginning on February 22, 2025.
/s/ Timothy C. Dec, as attorney-in-fact
2024-02-26